KIRAN KURAISHY: Open Payments
NPI 1871282335 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $206 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $168 |
| Astellas Pharma US Inc | 5 | $125 |
| SANOFI-AVENTIS U.S. LLC | 5 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
| Novo Nordisk Inc | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Corcept Therapeutics | 1 | $23 |
Products named: SPRAVATO, Veozah, TZIELD, XIFAXAN, Kerendia, MOUNJARO, Wegovy, Korlym.
Industry payments across GA — which companies pay providers there.
